Citation Formats
Comparative in vitro activities of meropenem in combination with colistin, levofloxacin, or chloramphenicol against Achromobacter xylosoxidans strains isolated from patients with cystic fibrosis
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

D. Damar-Çelik Et Al. , "Comparative in vitro activities of meropenem in combination with colistin, levofloxacin, or chloramphenicol against Achromobacter xylosoxidans strains isolated from patients with cystic fibrosis," Journal of Global Antimicrobial Resistance , vol.22, pp.713-717, 2020

Damar-Çelik, D. Et Al. 2020. Comparative in vitro activities of meropenem in combination with colistin, levofloxacin, or chloramphenicol against Achromobacter xylosoxidans strains isolated from patients with cystic fibrosis. Journal of Global Antimicrobial Resistance , vol.22 , 713-717.

Damar-Çelik, D., Nørskov-Lauritsen, N., & Özbek-Çelik, B., (2020). Comparative in vitro activities of meropenem in combination with colistin, levofloxacin, or chloramphenicol against Achromobacter xylosoxidans strains isolated from patients with cystic fibrosis. Journal of Global Antimicrobial Resistance , vol.22, 713-717.

Damar-Çelik, Damla, Niels Nørskov-Lauritsen, And Berna ÖZBEK ÇELİK. "Comparative in vitro activities of meropenem in combination with colistin, levofloxacin, or chloramphenicol against Achromobacter xylosoxidans strains isolated from patients with cystic fibrosis," Journal of Global Antimicrobial Resistance , vol.22, 713-717, 2020

Damar-Çelik, Damla Et Al. "Comparative in vitro activities of meropenem in combination with colistin, levofloxacin, or chloramphenicol against Achromobacter xylosoxidans strains isolated from patients with cystic fibrosis." Journal of Global Antimicrobial Resistance , vol.22, pp.713-717, 2020

Damar-Çelik, D. Nørskov-Lauritsen, N. And Özbek-Çelik, B. (2020) . "Comparative in vitro activities of meropenem in combination with colistin, levofloxacin, or chloramphenicol against Achromobacter xylosoxidans strains isolated from patients with cystic fibrosis." Journal of Global Antimicrobial Resistance , vol.22, pp.713-717.

@article{article, author={Damla Damar-Çelik Et Al. }, title={Comparative in vitro activities of meropenem in combination with colistin, levofloxacin, or chloramphenicol against Achromobacter xylosoxidans strains isolated from patients with cystic fibrosis}, journal={Journal of Global Antimicrobial Resistance}, year=2020, pages={713-717} }